tirzepatide and bone loss The promise of tirzepatide: A narrative review of metabolic benefits Tirzepatide for Medical Weight Loss

Brand-name drugs under patent protection (Mounjaro patent runs through 2036) dont have generic competition forcing prices down, and the manufacturer controls all rebate structures

Please check with your individual insurance or FSA/HSA to ensure they will allow IM Nutrient Therapy before treatment as we do not allow refunds if they choose not to reimburse

10.1093/ckj/sfad095 108

With existing FDA approval and established safety profiles, this class of medications presents a promising opportunity for repurposing in addiction treatment

Folate: 400-800 mcg daily

Clinical trials show sustained benefits over 72 weeks with continued GLP-1 and GIP receptor activation, though real-world treatment varies significantly based on patient-specific factors